OptimizeRx Corp — Director's Dealing 2014

Jun 9, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2014-03-28

Reporting Person: Harrell David (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-28	Common Stock	A	60938	—	Acquired	2766563	Direct
2014-05-01	Common Stock	A	100000	—	Acquired	2866563	Direct

Footnotes

F1: The Issuer issued these shares to the Reporting Person under the 2013 Incentive Plan.